Sur Access is a specialist consulting in market access for rare diseases, advising clients and partners on how to avoid pitfalls in rare disease drug development, strategic market positioning, reimbursement and pricing potential for your rare disease therapy.
We analyze your assets across multiple dimensions and enable you and your teams to make informed choices about the right indication, for the right patients, at the right time, on the right market and at the right price. Our mission is empowering businesses to navigate market access for rare diseases with confidence. 

Sur Access also specializes in the Croatian market. 
As the European Union introduces new pharmaceutical legislation aimed at expanding patient reach across the region, Sur is uniquely positioned to leverage Croatia's strategic location as a gateway to Southeast Europe. At Sur, we understand the complexities of entering new markets. That's why we offer comprehensive local expert guidance to help biotech companies navigate the Croatian market landscape. From establishing a local presence to facilitating smooth market entry, we act as your representative office in Croatia, ensuring a seamless transition. Our established relationships with key stakeholders, including healthcare providers, pharmacies, and regulatory authorities, allow us to provide invaluable insights and strategic advice on market positioning, reimbursement, and pricing potential. 
Let Sur be your partner in harnessing the potential of the Croatian market for regional expansion and beyond. Connect with us to explore how we can support your company's growth and success in this dynamic region.

Sur Access

Org chart

Teams

Offices